Prediction of the relationship between body weight and body condition score in sheep

During the whole production cycle it is important to monitor the energy balance and to quantify body reserve changes of the ewes. This can be done, both in experimental settings and in the field, by estimating the body condition score (BCS) of the ewes and its variations. However, if this tool is used to balance the diets it is necessary to know the relationship between BCS and body weight (BW), which varies depending on the mature size of the breed and of the population considered within each breed. The relationship between BW and BCS has been studied only for some sheep breeds and populations. For this reason, this research aimed to develop a prediction model of this relationship in ewes for any breed or population

Effects of triticale cultivars grown in a Mediterranean environment on biomass yield and quality

Triticale is a valuable crop in Mediterranean environments because its growth capacity at low temperatures and its precocity make it possible to obtain high biomass yields in early spring. Precocity of triticale is particularly appreciated in Mediterranean environment, where irrigation allows the sowing of a spring–summer corn crop after a winter cereal crop has been harvested for silage. In these conditions, early planted corn can take advantage of both longer-cycle cultivars and of the lower incidence of the European corn borer Ostrinia nubilalis attacks. Nutritional quality of triticale as forage is related to the phenological stage at harvest, cultivar choice, seeding rate and environmental conditions. The work reported in this paper was aimed at verifying if the hypothesized effects of the different habitus (cold requirement) of triticale cultivar grown at different seeding rates affect biomass quantity and quality at the stages of flowering and milk-waxy-maturity, which are the most relevant for triticale silage production

Effects of fibre and non-fibre carbohydrate and level of intake on microbial protein yield in Sarda sheep

Three studies using Sarda dairy sheep in dry, mid-lactation and late-lactation were carried out. Forty ewes for each physiological stage were fed 8 complete pelleted diets, which differed from each other in NDF and NFC content and source. Based on their main ingredient, diets were denominated: corn meal (CM), wheat middlings (WM), corn flakes (CF), barley meal (BM), corn cobs (CC), beet pulp (BP), alfalfa (AA), and soybean hulls (SH). In each study, rumen microbial protein (MCP) synthesis was estimated measuring urinary purine derivatives. In dry sheep, MCP synthesis was not affected by diet, while in mid- and late-lactation sheep dietary effects were observed. In mid-lactation, the highest MCP production was found for BM and BP (171 and 166 g/d, respectively), while the lowest was observed with AA (63 g/d). In late-lactation, the highest MCP yield (146 g/d) was observed in BP, while the lowest were for SH and CM. MCP synthesis, for each diet, was higher in mid-lactation than in latelactation, which in turn were higher than in the dry period. Dry matter intake (DMI) was positively associated to MCP. The MCP synthesis was best predicted by dietary energy (NEL) or digestible organic matter intake (dOMI)

A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors.

Fenretinide is a synthetic retinoid characterized by anticancer activity in preclinical models and favorable toxicological profile, but also by a low bioavailability that hindered its clinical efficacy in former clinical trials. We developed a new formulation of fenretinide complexed with 2-hydroxypropyl-beta-cyclodextrin (nanofenretinide) characterized by an increased bioavailability and therapeutic efficacy. Nanofenretinide was active in cell lines derived from multiple solid tumors, in primary spheroid cultures and in xenografts of lung and colorectal cancer, where it inhibited tumor growth independently from the mutational status of tumor cells. A global profiling of pathways activated by nanofenretinide was performed by reverse-phase proteomic arrays and lipid analysis, revealing widespread repression of the mTOR pathway, activation of apoptotic, autophagic and DNA damage signals and massive production of dihydroceramide, a bioactive lipid with pleiotropic effects on several biological processes. In cells that survived nanofenretinide treatment there was a decrease of factors involved in cell cycle progression and an increase in the levels of p16 and phosphorylated p38 MAPK with consequent block in G0 and early G1. The capacity of nanofenretinide to induce cancer cell death and quiescence, together with its elevated bioavailability and broad antitumor activity indicate its potential use in cancer treatment and chemoprevention

Localizing the 2030 Agenda at the Regional Level through the European Cohesion Policy: An Application to the Region of Sardinia

The 2030 Agenda represents a natural framework to guide the post-COVID recovery process. However, the assessment of the effectiveness of sustainable development-oriented policies is still a challenge, and addressing this problem is now more urgent than ever. Fondazione Eni Enrico Mattei and the Autonomous Region of Sardinia launched a research project aimed at developing a model to assess the extent to which the operational programs co-financed by the EU under the Cohesion Policy are sustainable in terms of SDGs. The method developed allows policymakers to direct spending toward investments to better pursue the 2030 Agenda targets. The paper presents the key features of the model and its results applied in the Sardinian context

An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile

Background Circulating tumor cells (CTCs) are responsible for the metastatic dissemination of colorectal cancer (CRC) to the liver, lungs and lymph nodes. CTCs rarity and heterogeneity strongly limit the elucidation of their biological features, as well as preclinical drug sensitivity studies aimed at metastasis prevention. Methods We generated organoids from CTCs isolated from an orthotopic CRC xenograft model. CTCs-derived organoids (CTCDOs) were characterized through proteome profiling, immunohistochemistry, immunofluorescence, flow cytometry, tumor-forming capacity and drug screening assays. The expression of intra- and extracellular markers found in CTCDOs was validated on CTCs isolated from the peripheral blood of CRC patients. Results CTCDOs exhibited a hybrid epithelial-mesenchymal transition (EMT) state and an increased expression of stemness-associated markers including the two homeobox transcription factors Goosecoid and Pancreatic Duodenal Homeobox Gene-1 (PDX1), which were also detected in CTCs from CRC patients. Functionally, CTCDOs showed a higher migratory/invasive ability and a different response to pathway-targeted drugs as compared to xenograft-derived organoids (XDOs). Specifically, CTCDOs were more sensitive than XDOs to drugs affecting the Survivin pathway, which decreased the levels of Survivin and X-Linked Inhibitor of Apoptosis Protein (XIAP) inducing CTCDOs death. Conclusions These results indicate that CTCDOs recapitulate several features of colorectal CTCs and may be used to investigate the features of metastatic CRC cells, to identify new prognostic biomarkers and to devise new potential strategies for metastasis prevention

A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer

Background: Quiescent/slow cycling cells have been identified in several tumors and correlated with therapy resistance. However, the features of chemoresistant populations and the molecular factors linking quiescence to chemoresistance are largely unknown. Methods: A population of chemoresistant quiescent/slow cycling cells was isolated through PKH26 staining (which allows to separate cells on the basis of their proliferation rate) from colorectal cancer (CRC) xenografts and subjected to global gene expression and pathway activation analyses. Factors expressed by the quiescent/slow cycling population were analyzed through lentiviral overexpression approaches for their ability to induce a dormant chemoresistant state both in vitro and in mouse xenografts. The correlation between quiescence-associated factors, CRC consensus molecular subtype and cancer prognosis was analyzed in large patient datasets. Results: Untreated colorectal tumors contain a population of quiescent/slow cycling cells with stem cell features (quiescent cancer stem cells, QCSCs) characterized by a predetermined mesenchymal-like chemoresistant phenotype. QCSCs expressed increased levels of ZEB2, a transcription factor involved in stem cell plasticity and epithelial-mesenchymal transition (EMT), and of antiapototic factors pCRAF and pASK1. ZEB2 overexpression upregulated pCRAF/pASK1 levels resulting in increased chemoresistance, enrichment of cells with stemness/EMT traits and proliferative slowdown of tumor xenografts. In parallel, chemotherapy treatment of tumor xenografts induced the prevalence of QCSCs with a stemness/EMT phenotype and activation of the ZEB2/pCRAF/pASK1 axis, resulting in a chemotherapy-unresponsive state. In CRC patients, increased ZEB2 levels correlated with worse relapse-free survival and were strongly associated to the consensus molecular subtype 4 (CMS4) characterized by dismal prognosis, decreased proliferative rates and upregulation of EMT genes.Conclusions: These results show that chemotherapy-naive tumors contain a cell population characterized by a coordinated program of chemoresistance, quiescence, stemness and EMT. Such population becomes prevalent upon drug treatment and is responsible for chemotherapy resistance, thus representing a key target for more effective therapeutic approaches